Insights
Practice Area
Capital Markets
Overview
Our Capital Markets practice group focuses on assisting clients in financing transactions. From start-ups seeking seed or venture capital to larger private and public equity and debt financings, our experience and expertise helps clients close successful deals. We are routinely involved in all types of private and public equity and debt financings, including:
- seed, venture capital, and private equity financings;
- IPOs and follow-on public offerings;
- registered “at the market” or ATM offerings, block trades, “bought deals,” and other creative financing and liquidity transactions;
- PIPEs (private investments in public equities);
- Rule 144A transactions;
- convertible and high-yield debt offerings; and
- complex credit facilities.
We are highly experienced and always stay abreast of changes in the law in these areas. Since January 2010, we have been involved in over 60 securities offerings by public companies raising in excess of $7 billion. We regularly advise over 20 public companies on the ever-changing world of the SEC and stock exchange rules, securities law compliance, disclosure, and corporate governance matters. In addition, our attorneys frequently give presentations at conferences about the latest capital markets and corporate governance developments, such as the JOBS Act’s changes to private placement general solicitation rules and the IPO on-ramp, as well as crowd-funding.
To discuss our Capital Markets expertise and services, please contact Don Reynolds at 919.865.2805 or dreynolds@wyrick.com.
Meet Our Team
Responsive, committed, client-centric relationships. We believe great people attract great clients and great clients attract great people.
View Full TeamSelect Transactions
Registered Direct Offering
of Common Stock
and Warrants
$76,500,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement
of Common Stock
and Warrants
$20,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement
of Common Stock
$31,416,800
These securities have been
previously sold. This announcement
appears as a matter of record only.
Public Offering
of Common Stock
$34,500,000
$32,000,000
Private Placement of Membership Units in 10 Federal Self Storage Acquisition Company 2, LLC
Private Placement of
Subordinated Notes
$18,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Public Offering
of Common Stock
$13,800,000
Initial Public Offering
$34,300,000
Private Placement of Convertible Preferred Stock
$80,000,010
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Subordinated Notes
$10,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
has acquired
Aevi Genomic Medicine, Inc.
$15.6M plus contingent
value rights up to $6.5M
Private Placement of
Subordinated Notes
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Fixed-to-Floating
Subordinated Notes
Due Dec 2029
$32,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Subordinated Notes
$10,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Public Offering
of Common Stock
$14,000,000
Lead Book-Running Manager
in the $31,050,000IPO for
Public Offering
$5,300,000
Common Stock Offering
$10,000,000
Secondary Public Offering
$316,542,774
Private Placement of Mandatory
Convertible Subordinated Notes
$18,550,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement of
Common Stock and
Convertible Preferred Stock
$15,200,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Follow-on Public Offering
of Common Stock
$3,400,000
$240,000,000
Rule 144A Offering of
1.25% Convertible Senior Notes
Due 2023
$10,000,000
Private Placement of Membership Units in 10 Federal Self Storage Acquisition Company 1, LLC
Follow-on Public Offering
of Common Stock
$63,250,008
Secondary Public Offering
$298,380,000
Receivables Securitization
Financing
$250,000,000
Private Placement
of Common Stock
$11,643,750
These securities have been
previously sold. This announcement
appears as a matter of record only.
Follow-on Public Offering
of Common Stock
$19,968,000
Common Stock
Rights Offering
$12,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement
of Common Stock
$30,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Private Placement
of Common Stock
$8,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
$19,500,000
Regulation A+ Offering
Private Placement of
Common Stock and Non-voting
Convertible Preferred Stock
$17,500,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Series B Financing
$10,000,000
has secured a
$30 million loan facility
from
Knight Therapeutics Inc.
$6,800,000
Public Offering
Series B Preferred Stock Financing
$5,000,000
$119,025,000
Public Offering
Private Placement
of Common Stock
$16,500,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
Seed Financing
$4,600,000
Series B Preferred Stock Financing
$2,200,000
Convertible Promissory Note
Financing of
StrideBio, Inc.
Class A Unit Financing
$2,500,000
Series A Preferred
Stock Financing of
Boragen, Inc.
$10,000,000
Private Placement
$94,500,000
Series Seed Preferred Stock
Financing
$2,150,000
Series B Preferred Stock
Financing
$20,000,000
Underwitten Public Offering of
Common Stock and Warrants
$8,600,000
Convertible Notes Investment in
Infacare Pharmaceutical
Corporation
Private Placement of
Subordinated Notes
$10,000,000
Series A Preferred Stock
Financing
$14,200,000
$193,500,000
Secondary Public Offering
$64,500,000
Share Repurchase
Series C Preferred Stock Financing
$6,200,000
Class A Unit Financing
$2,100,000
Series E Preferred Stock
Investment in
Phononic Devices, Inc.
$210,300,000
Secondary Public Offering
$28,750,000
Initial Public Offering
$360,960,000
Secondary Public Offering
Series A Preferred Stock Financing
$2,000,000
Series A-2 Financing
$2,000,000
$100,000,000
Public Offering
$272,100,000
Secondary Public Offering
$135,000,000
Share Repurchase
Series A investment in
Series A Preferred Stock
Financing
$11,000,000
$30,000,000
Common Stock PIPE Transaction
(investment in
The Medicines Company)
Private Placement of
Convertible Promissory Notes
$5,175,000
Series B Preferred Stock
Financing
$14,285,000
Series B Preferred Stock
Financing
$14,285,000
$358,000,000
Secondary Public Offering
$83,903,741
Secondary Public Offering
$93,500,000
Initial Public Offering
Series C Preferred Stock
Financing
$40,000,000
Series A Preferred Stock
Financing
Private Placement
of Common Stock
$7,800,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
$249,550,000
Secondary Public Offering
$150,000,000
Share Repurchase
Class D Preferred Share
Purchase
Private Placement of
Convertible Preferred Stock
$15,112,500
These securities have been
previously sold. This announcement
appears as a matter of record only.
Class B-1 Preferred Unit
Financing of
Nimbus Therapeutics, LLC
Strategic investment by
and expansion of
commercial relationship
with
Mercer
$74,700,000
Series B Preferred Stock
Financing
$33,000,000
Series A Expansion Round
$4,000,000
Series B Financing
$29,000,000
$147,900,000
Public Offering
Series A Financing of
$6,000,000
$172,500,000
Initial Public Offering
Private Placement
of Common Stock
$75,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
$17,500,000
5.0% Senior Convertible Notes
Due 2017
Series E Preferred Stock
Financing
$15,000,000
Revolving Credit Facility
Series C Preferred Stock
Financing
$9,100,000
Class A Preferred Units
Financing
$1,500,000
Private Placement
of 458,132,991 Shares
of Common Stock
$45,813,299
These securities have been
previously sold. This announcement
appears as a matter of record only.
has been acquired by
$1,100,000,000 cash
plus CVRs worth up to $353 million
Series A Preferred Stock
Financing
$11,000,000
Series C Preferred Stock
Investment in
Infacare Pharmaceutical
Corporation
$7,400,000
Registered Direct Offering
Series C Preferred Stock
Financing
$3,500,000
Placement Agent Counsel
for Private Placement of
Common Stock by
VantageSouth
Bancshares, Inc.
$47,000,000
These securities have been
previously sold. This announcement
appears as a matter of record only.
$27,000,000
Registered Direct Offering
$150,400,000
Initial Public Offering
Series E Preferred Stock
Financing
$11,746,248
Series A Preferred Stock
Financing
$5,000,000
Placement Agent Counsel
for Private Placement of
Convertible Preferred Stock by
Hometown Bankshares Corp.
These securities have been
previously sold. This announcement
appears as a matter of record only.
$8,900,000
Private Placement
$54,200,000
Public Offering
has accepted an investment
from
$1,500,000
Convertible Note Offering
investment in
Pharmaxis Ltd.
$40,000,000
Series A Preferred Stock
Financing
Private Investment in
Public Equity (PIPE)
$25,000,000
$16,000,000
Series A Preferred Stock
Financing
Series 1 Preferred Stock
Financing of
$100,000,000
Initial Public Offering
$5,495,237
Series B Preferred Stock
Financing of
$5,000,000
Secured Subordinated
Convertible Promissory Note
Financing
$3,600,000
Series C Preferred Stock
Financing
$4,750,000
Series B Preferred Stock
Financing of
$3,200,000
Subordinated Convertible
Promissory Note Financing
Series A Financing of
$690,000,000
Rule 144A Offering of
1.5% Convertible Notes
Due 2019
$58,000,000
Initial Public Offering
has been acquired byaffiliates of
The Carlyle Group
and
Hellman & Friedman
$3,900,000,000
$10,000,000
Loan and Security Agreement
$4,500,000
Series A Preferred Stock
Financing of
$13,900,000
Series B Preferred Stock
Financing of
Series 2011 Preferred Stock
Financing
Common Stock Financing
Common Stock Financing
$13,155,000
Series D Preferred Stock
Financing
$5,000,000
Unsecured Convertible
Promissory Note and
Warrant Financing
$51,750,000
Public Offering
$5,000,000
Series C Preferred Stock
Financing of
Credit Facility with
Wells Fargo Bank, N.A.
$35,000,000
Series D Preferred Stock
Financing
$3,000,000
Series A Preferred Stock
Financing of
Row Sham Bow, Inc.
Waste Industries
$750,000,000
Senior Secured Credit Facility
with
Bank of America
$20,000,000
Initial Public Offering
Series C-2 Preferred Stock
Financing
$35,000,000
Public Offering
$13,000,000Series C Preferred Stock
Financing
has spun off
as a separate
publicly traded company
$345,000,000
Offering of 2.75%
Senior Convertible Notes
Due 2015
$2,000,000
Series C-1 Preferred Stock
Financing
$1,570,000
Series AA Preferred Stock
Financing
Series A Preferred Stock
Financing
$3,500,000
Convertible Promissory Note
and Warrant Financing
$25,000,000
Series B Preferred Stock
Financing
$133,000,000
Public Offering
$6,100,000
Series C Preferred Stock
Financing
$2,310,996
Series C-1 Preferred Stock
Financing
has invested
$100,000,000
in
$12,300,000
Series C Preferred Stock
Financing
$13,300,000
Registered Direct Offering
$1,251,000
Private Placement
Common Stock Financing
$4,000,000
Secured Convertible Note
Financing
$5,000,000
Term Loan Financing
$8,000,000
Series B Preferred Stock
Financing
$18,000,000
Series B Preferred Stock
Financing
$46,000,000
Series C Preferred Stock
Financing
$6,300,000
Series C Preferred Stock
Financing
Secured Convertible Note
Financing
$35,000,000
Series A Preferred Stock
Redemption
$4,000,000
Subordinated Convertible Note
Financing
$2,000,000
Series A-3 Preferred Stock
Financing
$6,250,000
Series A Preferred Stock
Financing
$7,000,000
Series B-2 Convertible Preferred Stock
Financing
$5,000,000
Series D Preferred Stock
Financing
$60,000,000
Rule 144A Offering of
5.5% Convertible Notes
Due 2028
Waste Industries
Go Private Transaction
$749,000,000
$16,600,000
Series E Preferred Stock
Financing of
$11,400,000
Series B Preferred Stock
Financing of
$3,750,000
Credit Facility with
$3,050,000
Series B-1 Preferred Stock
Financing
$1,000,000
Preferred Stock Financing
$125,000,000
Loan Facility
to fund the acquisition of
the assets of
American Community
Newspapers LLC